BLADDER EA8185

Study #EA8185

Phase 2 Study of Bladder-Sparing Chemoradiation with MEDI4736 (durvalumab) in Clinical Stage 3, node Positive Bladder Cancer (INSPIRE)

Back To Clinical Trials